ImmunoPrecise Antibodies
SPONSORED
ImmunoPrecise Antibodies’ Subsidiary U-Protein Express Announces Exclusive Agreement as Global Supplier for Wnt-Surrogate-Fc Growth Factor
ImmunoPrecise Antibodies’ Subsidiary U-Protein Express Announces Exclusive Agreement as Global Supplier for Wnt-Surrogate-Fc Growth Factor (Sponsored)
VICTORIA, April 25, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd.(TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”) U-Protein Express, a wholly-owned ImmunoPrecise Antibodies subsidiary, in Utrecht, Netherlands, announced that it has obtained an exclusive license from Stanford University to ... [Read]
ImmunoPrecise Antibodies
SPONSORED
ImmunoPrecise to Present at the 2019 Bloom Burton and Co. Healthcare Investor Conference
ImmunoPrecise to Present at the 2019 Bloom Burton and Co. Healthcare Investor Conference (Sponsored)
VICTORIA, April 16, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd. (TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”)announced today that Jennifer Bath, President and CEO of ImmunoPrecise Antibodies, will present at the upcoming 2019 Bloom Burton & Co. Healthcare Investor Conference. Date: May 1st, ... [Read]
ImmunoPrecise Antibodies
SPONSORED
ImmunoPrecise Appoints Andy Nixon to Board of Directors
ImmunoPrecise Appoints Andy Nixon to Board of Directors (Sponsored)
VICTORIA, April 11, 2019 / – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2) (the “Company” or “IPA”) announces that it has appointed Andy Nixon, Vice President of Biotherapeutics Molecule Discovery at Boehringer Ingelheim, as a member of its board of ... [Read]